dilazep has been researched along with Acute Disease in 1 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
Acute Disease: Disease having a short and relatively severe course.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inage, H | 1 |
| Koyama, A | 1 |
| Narita, M | 1 |
| Tojo, S | 1 |
1 other study available for dilazep and Acute Disease
| Article | Year |
|---|---|
Effects of dilazep dihydrochloride (Dilazep) and its dose-dependent influence on rabbit acute serum sickness nephritis.
Topics: Acute Disease; Animals; Azepines; Dilazep; Male; Nephritis; Rabbits; Serum Sickness | 1985 |